Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 27.
Published in final edited form as: Mol Oral Microbiol. 2015 Oct 16;31(1):78–93. doi: 10.1111/omi.12131

High-throughput sequencing reveals key genes and immune homeostatic pathways activated in myeloid dendritic cells by Porphyromonas gingivalis 381 and its fimbrial mutants

P Arjunan 1,, A El-Awady 1,, RO Dannebaum 2, G Kunde-Ramamoorthy 2,3, CW Cutler 1,
PMCID: PMC5486950  NIHMSID: NIHMS859718  PMID: 26466817

SUMMARY

The human microbiome consists of highly diverse microbial communities that colonize our skin and mucosal surfaces, aiding in maintenance of immune homeostasis. The keystone pathogen Porphyromonas gingivalis induces a dysbiosis and disrupts immune homeostasis through as yet unclear mechanisms. The fimbrial adhesins of P. gingivalis facilitate biofilm formation, invasion of and dissemination by blood dendritic cells; hence, fimbriae may be key factors in disruption of immune homeostasis. In this study we employed RNA-seqencing transcriptome profiling to identify differentially expressed genes (DEGs) in human monocyte-derived dendritic cells (MoDCs) in response to in vitro infection/exposure by Pg381 or its isogenic mutant strains that solely express minor-Mfa1 fimbriae (DPG3), major-FimA fimbriae (MFI) or are deficient in both fimbriae (MFB) relative to uninfected control. Our results yielded a total of 479 DEGs that were at least twofold upregulated and downregulated in MoDCs significantly (P ≤ 0.05) by all four strains and certain DEGs that were strain-specific. Interestingly, the gene ontology biological and functional analysis shows that the upregulated genes in DPG3-induced MoDCs were more significant than other strains and associated with inflammation, immune response, anti-apoptosis, cell proliferation, and other homeostatic functions. Both transcriptome and quantitative polymerase chain reaction results show that DPG3, which solely expresses Mfa1, increased ZNF366, CD209, LOX1, IDO1, IL-10, CCL2, SOCS3, STAT3 and FOXO1 gene expression. In conclusion, we have identified key DC-mediated immune homeostatic pathways that could contribute to dysbiosis in periodontal infection with P. gingivalis.

Keywords: dendritic cells, dysbiosis, immune homeostasis, microbiome, Porphyromonas gingivalis, RNA-seqencing

INTRODUCTION

Periodontitis is a chronic inflammatory disease that entails progressive destruction of the supporting tissues of the dentition. Chronic periodontitis, which affects 47% of the US population (Eke et al., 2015), has been identified as a risk factor for multiple inflammatory diseases (Zhang et al., 2013). The intensive accumulation of microorganisms in the oral biofilm or dental plaque subjects the teeth and gingival tissues to high concentrations of bacterial metabolites, leading to a progressive inflammation. An aggregate of microorganisms, which comprise the human microbiota, resides on the surface and in deep layers of skin, oral mucosa and saliva, conjunctiva and in the gastrointestinal tracts. The presence of a symbiotic relationship between the host and microbiota significantly impacts on the immune system and is essential to maintenance of health. We recently described a diverse microbiome contained within the blood dendritic cells (DCs) of patients with chronic periodontitis, which could have a profound influence on systemic health (Carrion et al., 2012).

Porphyromonas gingivalis, a gram-negative anaerobe and oral amphibiont, is one of the most prominent microbes disseminated by blood DCs and has been recognized as a key causative microorganism in the pathogenesis of destructive chronic periodontitis (Griffen et al., 1998). Porphyromonas gingivalis effectively colonizes the oral tissues, multiplies rapidly with invasion and survives for protracted periods in the gingival epithelial cells (Yilmaz et al., 2006). It is postulated that the pathogenicity of P. gingivalis is multi-factorial and it possess a number of properties to enhance growth and survival, including those that regulate host inflammatory responses (Palm et al., 2013). The virulence factors of P. gingivalis can be characterized based on their involvement in colonization and attachment, evading host responses, and in damaging host tissues and dissemination. There is considerable diversity in strain and virulence of P. gingivalis depending upon the changes in either the pathogen itself or the host (Zenobia & Hajishengallis, 2015). Porphyromonas gingivalis also invades DCs, fibroblasts, and heart or aortic endothelial cells, brain, placenta, and other organs. In the oral cavity, P. gingivalis colonization changes the composition of the oral commensal microbiota accelerating microbiota-mediated bone-destructive periodontitis, signifying that this low-abundance species is a keystone in periodontal disease (Hajishengallis & Lambris, 2011). It can accumulate into complex multi-species consortia with other organisms (Kuboniwa & Lamont, 2010) resulting in the differential expression of a large percentage of its genome and proteome (Kuboniwa et al., 2009; Redanz et al., 2011).

Dendritic cells are highly migratory antigen-presenting cells that ‘patrol’ the blood, skin, mucosa, and all the major organ systems (El-Awady et al., 2015). These DCs, upon capture of microbes, undergo a tightly regulated series of events, including directed migration towards the secondary lymphoid organs, where processed antigens are ostensibly presented to T cells. This stimulates the adaptive immune response, generating distinct CD4 effector T helper responses (Miles et al., 2014). We have recently documented that P. gingivalis is able to subvert autophagic destruction within DCs, where autophagy is an integral component of microbial clearance, antigen processing and presentation by DCs (El-Awady et al., 2015). This occurs through its glycoprotein minor fimbriae called Mfa-1, which targets the C-type lectin DC-SIGN on DCs. It is shown that Mfa1 are immunosuppressive, compared with FimA (Zeituni et al., 2009); moreover, Mfa1 are essential for cell–cell auto-aggregation and recruitment for microcolony formation. The FimA have a chief role in initial attachment and organization of biofilms, as they act as adhesins that mediate invasion and colonization of host cells. The minor Mfa1 fimbriae interact with other dental commensals, co-adhere and develop biofilm in conjunction with Streptococcus gordonii (Lamont et al., 2002).

High-throughput RNA sequencing (RNA-seq) is recognized as a major quantitative transcriptome-profiling platform that aids in relating functional genomics to basic biology (Hirano et al., 2012). In the case of bacteria, small non-coding regulatory RNA mediated post-transcriptional regulation influences pathogenic bacteria to modulate their virulence and survival (Bardill & Hammer, 2012; Mann et al., 2012; Ortega et al., 2012), iron homeostasis and quorum sensing (Lenz et al., 2005). RNA sequencing generates millions of reads in a relatively short time and analyzes the transcriptome of eukaryotic genomes (Wang et al., 2009). The available literature states that a number of bacteria have been analyzed at the transcriptional level by deep sequencing approaches (Oliver et al., 2009; Perkins et al., 2009; Yoder-Himes et al., 2009; Beck et al., 2011; Isabella & Clark, 2011), which has provided novel insights into pathogenic regulons, as well as identifying sRNAs. As put forth by Hirano et al. (2012), with respect to the periodontopathogenic bacterium P. gingivalis, the transcriptome profiles generated genome-wide identification of transcription patterns (Hovik et al., 2012) using a targeted array approach has identified many putative novel small non-coding RNAs and the expression of few hypothetical genes validated. Recent studies have also used RNA-seq data to examine expression profiles of multiple immune cells (Hutchins et al., 2015).

We have shown in our previous studies that engagement of DC–specific ICAM–3 grabbing non-integrin (DC–SIGN) by Mfa1 fimbriae of P. gingivalis yields weak DC maturation and an immunosuppressive cytokine profile. Furthermore, DC-SIGN–Toll-like receptor 2 (TLR2) crosstalk determines the intracellular fate of this pathogen within DCs, and may have implications for the management of many low-grade infections (El-Awady et al., 2015). We hypothesize that bacteremic oral pathogens taken up by blood DCs activate specific genes and pathways responsible for disruption of immune homeostasis in chronic periodontitis. In our recent review, we also speculated that the frequency and phenotype of blood mDCs along with an assessment of the transcriptome and microbiome may provide a diagnostic tool for assessing patient risk for chronic inflammation (Miles et al., 2014). Given these facts, in order to establish the immune homeostatic pathways disrupted in chronic periodontitis and to identify the genes in human myeloid DCs, as a first report, we have documented here two novel approaches using P. gingivalis 381 and bacterial mutants that solely express minor-Mfa1 fimbriae (DPG3), major-FimA fimbriae (MFI) or are deficient in both fimbriae (MFB) relative to uninfected control. We performed RNA sequencing of human monocyte-derived DCs (MoDCs) subjected to in vitro infection with Pg381 or its defined isogenic mutants. This transcriptome analysis demonstrates the important and distinctive roles that the fimbriae play in disruption of DC-mediated immune homeostatic pathways that could contribute to dysbiosis in periodontitis. Overall, our investigation advances our understanding of the molecular basis of gene regulation during P. gingivalis-mediated disease progression and also sheds light on how microbes interact with human DCs.

METHODS

Cultivation and phenotypic characterization of MoDCs

The Human Assurance Committee (HAC) at Georgia Regents University approved this protocol involving human cells. All human subject studies conducted conform to the principles of the Declaration of Helsinki. This study was human subject exempt as all monocytes were obtained from healthy anonymous donors. The conventional MoDCs were generated in vitro as described elsewhere (Sallusto & Lanzavecchia, 1994), with slight modifications. Briefly, human monocytes were isolated from mononuclear fractions of peripheral human blood by a human monocyte enrichment technique. Ethylenediamine tetraacetic acid (EDTA) was added to the whole blood (1 mM) and samples were incubated with the RosetteSepTM Human Monocyte Enrichment Cocktail kit (StemCell Technologies Inc., Vancouver, BC, Canada) for 20 min. Samples were diluted with an equal volume of phosphate-buffered saline (PBS) + 2% fetal bovine serum and 1 mM EDTA and layers of diluted samples were placed on the top of medium-density Ficoll. Monocyte separation was carried out using medium density Ficoll (GE Health-care Bio-Sciences, Piscataway, NJ). Samples were centrifuged at 1200 g for 20 min at room temperature. The layer of enriched cells was removed and washed twice with PBS and re-suspended in medium for cell culture. Cells were seeded in the presence of granulocyte–macrophage colony-stimlating factor (GM-CSF)/ interleukin-4 (IL-4) (1000 unit ml−1) (Gemini Bio-Product, GA, Broderick, CA) at a concentration of 3 × 105 to 4 × 105 cells ml−1 for 5–6 days. Fresh medium treated with GM-CSF and IL-4 was used every other day for cultured cells. Flow cytometry analyses were carried out to verify the immature DC phenotype (CD1a+ CD83 CD14 DC-SIGN+) (Carrion et al., 2012; Miles et al., 2014; El-Awady et al., 2015) Cell surface markers of DCs were evaluated by four-color immunofluorescence staining with the following antibodies: phycoerythrin-conjugated CD1a, fluorescein iosthiocyanate-conjugated DC-SIGN, Peridinin chlorophyll protein-conjugated CD14, and allophycocyanin-conjugated CD83 (Miltenyi Biotec, Bergisch Gladbach, Germany). After 30 min at 4°C and washing with staining buffer (PBS pH 7.2, 2 mM EDTA, and 2% fetal bovine serum), cells were fixed in 1% paraformaldehyde. Positive marker expression was calculated as a percentage of total DCs by forward scatter and side scatter characteristics (Zeituni et al., 2009, 2010a).

Porphyromonas gingivalis strains and mutants

Four P. gingivalis strains were used in this study and were obtained courtesy of C.A. Genco (Tufts University School of Medicine, Boston, MA): (i) Pg381, which expresses both minor (Mfa1) and major (FimA) fimbriae; (ii) isogenic minor-Mfa1 fimbria-deficient mutant (MFI), which expresses only the major-FimA fimbriae; (iii) isogenic major-FimA fimbria-deficient mutant (DPG3), which expresses only the minor-Mfa1 fimbriae; and (iv) the double fimbriae mutant (MFB) (Takahashi et al., 2006) (Table 1). The P. gingivalis strains were maintained anaerobically (10% H2, 10% CO2 and 80% N2) in a Forma Scientific anaerobic system glove box model 1025/ 1029 at 37°C in Difco anaerobe broth MIC (Gibson et al., 2006). Mutant strains were maintained using erythromycin (5 μg ml−1) for mutant DPG3, tetracycline (2 μg ml−1) for mutant MFI and both erythromycin and tetracycline for the double fimbriae mutant MFB.

Table 1.

Porphyromonas gingivalis wild type and isogenic fimbriae-deficient mutant strains

Strain Phenotype Genotype Predominant PRRs targeted
Pg381 mfa1+/fimA+ 381 DC-SIGN/TLR2
Pg-DPG3 mfa1+/fimA− 381ΔfimA DC-SIGN
Pg-MFI mfa1−/fimA+ 381Δmfa1 TLR2
Pg-MFB mfa1−/fimA− 381ΔfimA
Δmfa1
TLRs

PRR, pattern recognition receptor; TLR, Toll-like receptor.

DC infection with P. gingivalis

Bacterial suspensions were washed five times in PBS and re-suspended for spectrophotometer reading of 0.11 for optical density at 660 nm, which was previously determined to be equal to 5 × 107 colony-forming units (Cutler et al., 1991). Corresponding bacterial counts were calculated and dilutions were prepared to infect MoDCs at a multiplicity of infection (MOI) of 10 : 1. Bacterial suspensions were washed three times with PBS before MoDC infection. The MoDCs were co-incubated with Pg381, DPG3, MFI, and MFB and incubated for 12 h. Four biological replicates were prepared for each strain.

RNA isolation and purification

After 12 h of infection, direct lysis of the infected MoDC suspensions was achieved by adding 350 μl of Qiagen’s buffer RLT (Qiagen, Hilden, Germany). The lysate was collected and pipetted directly into the Qia-shredder spin column. Ethanol (70%) was added to the lysate, which was mixed by pipetting. Samples were then transferred to RNeasy spin columns placed in 2-ml collection tubes. The samples were centrifuged at 11,963 g for 15 s. The flow-through was discarded and 700 μl of buffer RW1 was added to the spin column. The samples were centrifuged at 11,963 g for 15 s. The flow-through was discarded and 500 μl of buffer RBE was added to the spin column. The buffer RBE step was repeated; then the spin column was placed in a 1.5-ml collection tube. RNA-free water (20 μl) was added directly to the spin column membrane, and the samples were centrifuged at 11,963 g for 1 min. All steps of the procedure were performed at room temperature, and all centrifugation was performed at 20–25°C in a standard microcentrifuge. RNA quantity and integrity were tested and only ratios of absorbance at 260 and 280 nm of 1.8–2.0, were included in the study. Samples were then stored at −80°C for further RNA-seq studies.

RNA-seq library preparation and sequencing

High-molecular-weight (> 200 nucleotides) RNA (300 ng) was pooled from three individual wells within each strain phenotype: Pg381, DPG3, MFI, MFB and uninfected control, for a total of five samples. For each strain, two pools of 900 ng of RNA were created and libraries were prepared using Illumina regular approach. The rationale for pooling the RNA from individual samples was to obtain sufficient quantities of RNA for library preparation using samples. Illumina TruSeq RNA Sample Prep Kit (Illumina Inc., San Diego, CA) was used with 800 ng of total RNA for the construction of sequencing libraries. RNA libraries were prepared for sequencing using standard Illumina protocols. In brief, RNA was purified using Sera-Mag Magnetic Oligo(dT) beads and fragmented, followed by cDNA synthesis with random hexamers. This product then underwent end repair, adapter ligation, and gel purification (2% TAE) to isolate 300-nucleotide fragments. DNA from the gel bands was purified using the QIAquick Gel Extraction Kit, polymerase chain reaction (PCR) amplified (15 cycles), and libraries were quantified using an Agilent bioanalyzer (DNA-1000 kit). Each library was sequenced using Illumina GAIIX sequencer on one lane of the flow cell, generating 50-nucleotide paired-end reads.

Data processing

The raw reads were processed using cutadapt (http://journal.embnet.org/index.php/embnetjournal/article/view/200/458) to filter for low-quality bases (QV < 20) and trimming of adapter sequences. After trimming, any reads with < 32 bp were also filtered out. High-quality reads were then aligned to the ribosomal RNA database to remove rRNA reads using in-house perl scripts.

Principal component analysis

For quantifying gene expression data from the signal-processing viewpoint, samples correlation and detection of outliers, the raw data (all transcripts) were subjected to a principal component analysis (PCA) before cluster exploration using Partek® Software as previously described (Koh et al., 2012). Samples were plotted in three-dimensional plots across the first three principal components and the five conditions (Pg381, DPG3, MFI, MFB and uninfected control) were studied. The plot of PC1 (x-axis), PC2 (y-axis), and PC3 (z-axis) gave rise to ~95% of the variability, revealing distinct clusters corresponding to the conditions.

Differential gene expression, functional, and pathway analysis

Filtered high-quality RNA-seq data sets (see Table S1) were aligned against the hg38/GRCh38 human genome build (see Fig. S1) using the splice-aware aligner tophat (Trapnell et al., 2012). Normalized gene counts were obtained with cufflinks/2.2.1 with default parameters and differential gene expression between the untreated and treated samples was investigated using cuffdiff with default parameters (Trapnell et al., 2012). Genes were defined as expressed using an average minimum fragments per kilo base per million reads (FPKM) value of 2 across all samples and transcript length ≥ 300 bp. In each comparison, a gene is defined as differentially expressed using a fold change of ≥2, average FPKM ≥5 and P ≤ 0.05. R scripts were written using the packages gplot, heatmap.2, Venn diagram, and topGO. Clustering and visualization of differentially expressed transcripts as heatmaps were generated using heatmap.2. Overlaps between differentially expressed genes were performed using Venn diagram tools and biological processes were assessed with topGO. A classic Fisher test was used to define enriched Gene Ontology (GO) terms compared with the background of expressed transcripts with P ≤ 0.01. Genes involved in different steps of a common pathway tend to overlap in their expression profiles. As such, pathway-based analysis can provide insights into the biological functions of genes. Functional and pathway analysis was performed using GO terms/biological process and annotated genes. All the raw FASTQ data generated in this study using the Illumina protocols have been deposited in GEO Series GSE67141.

TaqMan PCR array of MoDCs

Analysis of gene expression in Pg381, DPG3, MFI, and MFB infected MoDCs was performed by real-time quantitative PCR (RT-qPCR) using the aliquots of the same total RNA isolated as described above. Briefly, cDNA was synthesized using 1 μg RNA through a reverse-transcription reaction (Applied Biosystems, Foster City, CA). Quantitative RT-PCR was performed on TaqMan array fast plates using TaqMan fast universal PCR master mix (2×). Three experimental (technical) replicates were analyzed for each biological sample. The calculations for fold regulation used the 2−ΔΔCt method. The fold regulation of the gene in each group was calculated relative to its expression in the controlled samples for that gene, and normalized with 18S rRNA as an internal control.

RESULTS

Purity of mDCs and RNA-seq profiling quality analysis

Isolated immature DCs were over 96% pure, as determined by phenotypic markers as described (El-Awady et al., 2015). To understand the transcriptional events in MoDCs associated with pathogen P. gingivalis and its fimbriae mutants, we performed high-throughput RNA-seq of poly-A purified RNA samples using an Illumina Genome Analyzer. Figure S1 shows that approximately 50 million high-quality reads were obtained per sample after filtering for base quality, adapter trimming, and rRNA reads. Of these high-quality reads, 48 million (~94%) reads were aligned and properly paired to the human mRNA reference sequences (see Fig. S1B) and 20,900 transcripts were measured in DCs. Fragments per kilobase of exon per FPKM was used to represent the expression level of each transcript as shown in the (Fig. S1C–E) (Mortazavi et al., 2008). Among the transcripts obtained, 20,900 transcripts and their variants with stringent filter criteria of P ≤ 0.05 and the absolute log2-fold change ≥ 2 were annotated to 479 differentially expressed genes (see Table S1).

Principal component analysis

To identify possible correlations between genes altered by different strains of P. gingivalis and their fimbrial phenotypes and genotypes (Table 1) we performed a PCA (Fig. 1A). The PCA shows interesting and not-unexpected results, demonstrating the scattered samples among the three PCA components, which clearly indicate a strain-specific gene expression pattern. The first component result shows that Pg381, DPG3, and MFI are distinctly separated from uninfected control and MFB (double mutant). The second components show that genes induced in MoDCs by Pg381 and MFI (both FimA+) and DPG3 (FimA−) are strongly related to the strain’s phenotype (Table 1), as the strains that might have more or less similar virulence tend to cluster together. As expected, when the third PCA component is taken into account, the genes of MoDCs infected with DPG3 are further separated from the genes of MoDCs infected with Pg381 and MFI, according to the virulence level of the mutant, although it is clustered in the same PCA pattern. Environmental cues are particularly influential in fimbriae expression patterns of P. gingivalis (Xie et al., 1997). These data further suggest the important role that the local environment can play in host immune cell gene regulation by P. gingivalis (Xie et al., 1997).

Figure 1.

Figure 1

Principal component, hierarchical clustergram and Venn analyses. (A) Principal component analysis shows good agreement with sample correlation: Pg381, DPG3, and MFI are similar and distinctly separated from uninfected control (Ui. Ctrl) monocyte-derived dendritic cells (MoDCs) and MFB (the double mutant), which are also similar. The DPG3 is clearly separated from Pg381 and MFI as well. (B) Hierarchical cluster analysis performed on the profiles of 479 differentially expressed transcripts. The heatmap of log2 (fold change) of samples compared with uninfected control shows correlation in differential expression levels (rows) over DPG3, Pg381, and MFI with subtle changes in MFB (columns). Heatmap for fold changes over uninfected control shown on the left. Deep red and blue are genes ≥ 10-fold upregulated and ≥ 10-fold downregulated, respectively. Note that the DPG3 and MFB are deviated from Pg381 and MFI, as shown in the principal components analysis. (C) Four-way Venn diagram comparison of the differentially expressed genes shows that Pg381, DPG3, and MFI share most of the genes in common (243) from uninfected control. The MFB genes do not overlap with other strains as well as uninfected control, though only a few of the genes are altered. (D) Comparison of fragments per kilo base per million reads (FPKM) value differences by individual strain. Subcluster-gram shows the differential expression of genes in genetic mutants of Porphyromonas gingivalis strains in DCs compared with the uninfected control (Tables S2 and S3). The pseudo colored representation of transcript expression is shown according to the scale at the top of each cluster, respectively.

Transcriptome profiling of in vitro MoDCs

RNA-seq was employed to profile the global transcriptome changes induced in DCs by infection with different fimbriae expressing P. gingivalis strains (DPG3, MFI, and MFB) in three experimental replicate cultures. To achieve our goal, first unsupervised hierarchical clustering was performed on 479 differentially expressed genes of MoDCs infected by MOI of 10 for 12 h of Pg381, DPG3, MFI, and MFB relative to uninfected control. The conditional and hierarchical cluster-grams clearly indicate the clustered samples (per strain) in the column and the highly upregulated (red) and downregulated (blue) genes in the rows (Fig. 1B). The differential expression patterns demonstrate clustering of most of the up-regulated and down-regulated genes are related to the Pg381, DPG3, and MFI strain’s virulent dependent manner. Expression patterns of Pg381, DPG3, and MFI infected groups are similar, whereas a variation in expression patterns is evident in the double mutant MFB. This cluster trend is further confirmation of the PCA as shown in Fig. 1A.

Next, we used the Venn diagram analysis for shared and unique genes induced by P. gingivalis strains compared with uninfected control (Fig. 1C). Results of our analysis yielded a total of 479 differentially expressed genes in MoDCs that passed all stringent filters including ≥ 2-fold upregulated and downregulated in all four strains (Pg381-338, DPG3-350, MFI-318, and MFB-42), significantly (P ≤ 0.05), compared with the uninfected control, using cuffdiff. Among these, 243 genes were commonly altered by three strains, Pg381, DPG3, and MFI, whereas none of the genes were altered commonly between these and MFB double mutants (except for two genes shared with DPG3), which were mostly comparable with the uninfected control. Remarkably, 70 genes in MoDCs were uniquely differentially expressed in response to DPG3, 24 in Pg381, 20 in MFI, and 40 in MFB. In addition, 25 genes were shared in response to Pg381 and DPG3, 10 between DPG3 and MFI, and 48 between Pg381 and MFI. To visualize the differentially expressed genes, we clustered each strain individually compared with the uninfected control (Fig. 1D). These tightly clustered and functionally congregated upregulated and downregulated genes were selected and are listed in the (Tables S2–S5).

Further analyses revealed the distribution of differentially upregulated and downregulated genes using MA (Fig. 2) and scatter (inset) plots based on log2-fold change compared with average expression 5 FPKM. The MA plot shows, respectively, 200 and 138 genes upregulated and downregulated in MoDCs in response to Pg381 (Fig. 2A), 238 and 118 increased and decreased in response to DPG3 (Fig. 2B), 188 and 130 increased and decreased in response to MFI (Fig. 2C), but only 40 altered (18 upregulated and 24 downregulated) in response to MFB (Fig. 2D), relative to the uninfected control. This indicates that P. gingivalis MFB, which is not internalized by MoDCs, nonetheless induces 40 differentially expressed genes. In contrast, DPG3 and MFI, which were both taken up by MoDCs, induced distinct changes in genes and homeostatic pathways in MoDCs likely reflective of distinct pattern recognition receptor crosstalk by Mfa1 and FimA. The expression and distribution of genes shown in scatter plots (Inset) indicate the similar trend and the reliability of gene expressions induced by P. gingivalis and its mutant strains.

Figure 2.

Figure 2

MA and scatter plots for transcripts distribution analyses. MA plots for the average expression and fold changes in log scale to visualize the change in gene expression and distribution against uninfected control for all 20,900 transcripts (A–D). Note: some values cannot be displayed in log space, a majority of the genes defined as significant have a 0 fragments per kilo base per million reads (FPKM) in one sample (bottom right plot). Scatter plots for comparison of FPKM for coding sequences (inset). For all four strains, each locus has one point with the log2 FPKM in one strain plotted against the log2 FPKM of the uninfected control. The straight line shows identity (A) Pg381 vs. Uninfected Control, (B) DPG3 vs. Uninfected Control, (C) MFI vs. Uninfected Control, and (D) MFB vs. Uninfected Control. Red, blue, and black colored data points indicate upregulated, downregulated and unaltered, respectively, as well as demonstrating the significant relative abundance differences between uninfected control monocyte-derived dendritic cells and infected with Porphyromonas gingivalis plus its mutant strains.

Functional categories and enriched pathways

After analysis of the differentially expressed genes in MoDCs by Pg381 and its mutants, our interest turned towards the genes that were uniquely altered by each strain in comparison with the uninfected control (Fig. 3A–D). These unique genes are also listed in the (Tables S2–S5). Among the 479 identified genes in total, 154 were found to correspond to unique genes shown as clustergram in Fig. 3(B–D), respectively. These include 24 genes induced by Pg381-, 70 by DPG3-, 20 by MFI-, and 40 by MFB-infected cells. To characterize these genes, we initially categorized them based on biological process terms of GO and conducted an enrichment analysis. The most significant categories are shown in the functional pie-charts (Fig. 4). These processes include apoptosis in response to Pg381 (16%) and MFI (18%), anti-apoptotic processes in response to DPG3 (20%), and immune effector process in response to MFB (15%) -infected cells. Further interesting gene-mediated functions affected by Pg381 are angiogenesis (7%), immune response (16%), immune effectors (10%), IL-17 production (1%) and regulation of chemokine production (2%), bone resorption (2%), and CD40 signaling/TLR2/4 signaling pathways (7%) (Fig. 4A). In contrast, processes influenced most by DPG3 (Fig. 4B) include immune-homeostasis (10%), dendritic/cell migration/differentiation (17%), proliferation (20%), negative regulation of apoptotic-signaling pathways (4%), and others listed. Strain MFI (Fig. 4C) induced immune/inflammatory response (27%), programmed cell death/positive regulation of apoptosis (27%), bone remodeling/resorption (5%), phagolysosome assembly/phagocytosis (2%), cytokine-mediated and TLR2 signaling pathways (7%); while MFB (Fig. 4D) influenced activated T-cell proliferation (5%), innate immune response (15), regulation of IL-2 production (2%) and TLR signaling pathways (10). Furthermore, the predicted molecular function and subcellular localization of the identified genes were also retrieved from GO and enrichment analysis (see Tables S2–S3). All 154 genes were then classified into five major groups upon which we focused according to their molecular function, as follows: immune-inflammatory response, apoptotic activities, immune-homeostatic regulation, differentiation, and migration.

Figure 3.

Figure 3

Unique and functional cluster analysis. (A–E) The Venn and cluster-gram shows the uniqueness of each genetic mutant of Porphyromonas gingivalis based on the available annotated genes, fold (≥ ± 2) change, CuffDiff defined P-value comparison between observed and expected differentially expressed genes in a gene ontology term (see the gene list in the Tables S2–S5). Analyzed results demonstrate the set of genes that are uniquely and differentially expressed in dendritic cells (DCs) based on the virulence level of each mutant strain (B–D). (E) TaqMan quantitative polymerase chain reaction results shows the key annotated genes are strongly influenced by DPG3-infected DCs. Note: both, RNA-seqencing and quantitative polymerase chain reaction demonstrate the similar trend in expression level at fold changes. Genes were declared to be differentially expressed by comparing four types of P. gingivalis strains requiring the filter criteria as mentioned above.

Figure 4.

Figure 4

Functional categorization. Pie chart shows the classification of differentially expressed genes based on relevant biological processes (Gene Ontology terms) of four strains, (A) Pg381; (B) DPG3, (C) MFI, and (D) MFB relative to uninfected control. The pie chart depicts the major function of Pg381 (Apoptosis/inflammatory response) and its fimbriae mutants, DGP3 (cell proliferation/survival/dissemination), MFI (bone resorption/programmed cell death), MFB (feeble pattern recognition receptor signaling/immune effector process).

Validation of differentially expressed genes data by RT-qPCR array

In a separate series of experiments, MoDCs were infected with P. gingivalis and its mutants for 12 h. An array of 17 genes (Table 2) related to DC phenotype, maturation, inflammation and migration profiles of DCs were investigated by our in-house TaqMan qPCR array. The results are as follows.

Table 2.

Quantitative TaqMan-PCR array of monocyte-derived dendritic cells infected with Pg381, DPG3, MFI and MFB strains

Functional group Gene name Pg381
DPG3
MFI
MFB
Fold P-value Fold P-value Fold P-value Fold P-value
Phenotype/maturation CD1A −3.9 0.0270* −1.7 0.0814 −3.4 0.0170** −2.3 0.0534*
CD1C −4.0 0.0280* −3.7 0.0258* −3.6 0.0441* −4.2 0.0212*
CD209 −4.0 0.0001*** 6.9 0.0188** −0.5 0.2196 −4.1 0.0002***
CD36 −3.9 0.0228* −3.7 0.0197** −3.6 0.0176** −4.1 0.0277*
CD80 4.8 0.0238* 5.5 0.0237* 2.6 0.1034 2.2 0.1160
Inflammation IDO1 76.5 0.0041** 151.4 0.0159** 54.4 0.0068** 32.4 0.0062**
IL6 52.0 0.0210* 34.0 0.0361* 50.0 0.0232* −3.5 0.0253*
LOX1 1.8 0.0262* 8.6 0.0141** 0.3 0.4542 3.7 0.0260*
TIMP1 4.1 0.0305* 9.2 0.0060** 4.6 0.0094** 2.0 0.1523
TLR2 4.1 0.0307* 4.3 0.0271* 4.0 0.0133** 2.0 0.1293
TLR4 −2.0 0.0974 −1.9 0.0889 −3.7 0.0410* −4.1 0.0293*
Migration CCL19 2.3 0.0204* 2.9 0.0944 1.4 0.2986 −1.5 0.0046**
CCL21 −7.1 0.0084** −3.1 0.0155** −4.2 0.0015*** −9.1 0.0020**
CCL5 4.2 0.0291* 9.2 0.0095** 4.5 0.0156** 2.0 0.1572
CCR2 −5.4 0.0162** −2.4 0.0414* −1.9 0.1652 −5.8 0.0045**
CCR7 8.4 0.0017*** 17.9 0.0157** 0.1 0.4449 4.0 0.0008***
CX3CR1 −3.4 0.0190** −2.3 0.0051** −0.7 0.3121 −3.2 0.0107**

ND, not detectable.

The statistical analysis of fold regulations (2−ΔΔCT) was performed using the t-test with uninfected controls within three different experiments (*P < 0.05; **P < 0.01; ***P < 0.001).

DC phenotype and maturation state

Pg381 infection significantly downregulated the immaturity marker DC-SIGN in MoDCs (−4.0-fold, P = 0.0001) whereas DPG-3 upregulated DC-SIGN (CD209) mRNA (+6.9-fold, P = 0.0188). Both Pg381 and DPG-3 significantly downregulated the expression of CD1a, CD1c, and CD36. In addition, both strains upregulated CD80 mRNA (+4.8-fold, P = 0.023) (+5.5-fold, P = 0.023), respectively. MFI infection significantly downregulated the expression of CD1a, CD1c, and CD36 (−3.4, −3.6, and −3.6-fold), respectively. In contrast strain MFB, which is not taken up by MoDCs, downregulated CD1c and CD36 mRNA (−4.2-fold and −4.1-fold). Moreover, MFB infection downregulated DC-SIGN (CD209) mRNA (−4.1-fold, P = 0.027). No significant changes were detected in the expression of CD14, CD40, CD83, and CD86 after infection with all strains (Table 2).

Immunoregulatory and inflammatory/atherogenesis markers

These markers showed a distinct pattern of expression when comparing Pg381 to DPG-3 infections. Indoleamine 2,3-dioxygenase 1 (IDO1) mRNA was significantly upregulated in MoDCs after infection with DPG-3 (+151-fold, P = 0.015), Pg381 (+76.5-fold, P = 0.004) and MFI (+54.4-fold, P = 0.0.006), whereas the lowest upregulation of IDO1 was in MFB-infected cells (+32.4-fold, P = 0.006). In addition, Lox1/OLR1 mRNA was significantly upregulated in cells infected with DPG-3 (+8.6-fold, P = 0.014). The change in Lox1 expression in MoDCs infected with Pg381 was < 2-fold (+1.8, P = 0.026). No significant change was detected in Lox1 expression after MFI infection, whereas slight upregulation of the gene was recorded in MFB-infected cells (+3.7-fold, P = 0.029). No significant change was detected in the expression of matrix metalloproteases (1, 8 and 9) among cells infected with all P. gingivalis strains, although the tissue inhibitor of matrix metalloproteases, TIMP1, was upregulated by all strains. Fimbriated strains (Pg381, DPG3, and MFI) significantly upregulated TLR2 (~ +4-fold), whereas MFB did not change the gene expression within MoDCs. Although all strains downregulated TLR4 expression, the statistical significance was only achieved in MFI- and MFB-infected cells (−3.7, P = 0.041) (−4.1, P = 0.029), respectively (Table 2).

Inflammatory cell recruitment and homing

Pg381 infection significantly upregulated CCL19, CCL5, and CCR7 mRNA 2.3-, 4.2-, and 8.4-fold, respectively, in MoDCs while Pg381 downregulated CCL21, CCR2, and CXCL16 mRNA (−7.1, −5.4, and −3.4-fold). In contrast, DPG3 significantly downregulated CCL21, CCR2, and CX3CR1 (−3.1, −2.4, and −2.3-fold) in MoDCs. Those MoDCs infected with MFI strains showed upregulation of CCL5 (+4.5-fold, P = 0.015) and downregulation of CCL21 (−4.2-fold, P = 0.001). In addition, cells infected with MFB exhibited significant downregulation in CCL19, CCL21, CCR2, and CX3CR1 mRNA (−1.5, −9.1, −5.8 and − 3.2-fold) (Table 2).

We also confirmed several key annotated genes activated in DCs by DPG3 (Fig. 3B, E), which are mainly involved in regulation of DC differentiation (ZNF366) programmed cell death (apoptosis) [Fork-head box protein O1 (FOXO1)], DC recruitment (CCL2, CCR7) intracellular signaling [suppressor of cytokine signaling 3 (SOCS3), signal transducer and activator of transcription 3 (STAT3)] uptake of low-density lipoproteins (LOX1) and immunoregulation (DC-SIGN, IL-10, IDO1) compared with uninfected control. Among the upregulated genes examined by qPCR, IDO1 was the gene most significantly (P < 0.001) upregulated more than 50-fold by DPG3 (Mfa1) relative to uninfected control. Overall, the expression changes of nine selected genes validated by TaqMan qPCR data show the similar trend from RNA-seq analysis (Fig. 3E).

DISCUSSION

A major determinant of P. gingivalis pathogenicity in chronic periodontitis and its impact on immune homeostasis has been attributed to fimbriae expression. The fimbriae mediate initial interactions with the host that are imperative for the initiation and progression of periodontal diseases (Lamont & Jenkinson, 1998). Porphyromonas gingivalis plays a particularly influential role in periodontal pathogenesis by disrupting the local microbiome (Hajishengallis & Lambris, 2011), invading the host epithelial barrier (Njoroge et al., 1997) and evading autophagy in DCs (El-Awady et al., 2015). Here we used RNA-seq to analyze globally the transcripts induced in DCs by infection with different fimbriae-expressing P. gingivalis strains. The RNA-seq method is regarded as a powerful digital gene expression measurement with many advantages over previous microarray-based assays; in particular, its ability to sensitively analyze transcriptomes in an unbiased and comprehensive manner (‘t Hoen et al., 2008; Wilhelm et al., 2008). Through this approach we were able to identify certain key immune homeostatic pathways that are disrupted by P. gingivalis infection; moreover, many pathways are induced in a fimbriae-specific manner. We will focus our discussion on several key annotated genes activated in our in vitro DC infection model that were dependent on the fimbrial expression pattern of the infecting P. gingivalis strain.

DC-SIGN has emerged as a key player in the induction of immune responses against numerous pathogens via modulation of TLR-induced immune activation (Sukhithasri et al., 2013). We have previously observed that the native minor Mfa1 fimbriae of P. gingivalis are glycosylated proteins with mannose and fucose residues (Zeituni et al., 2010b) required for binding to the endocytic receptor DC-SIGN, leading to internalization in DC-SIGN-rich compartments. This uncouples cytokine secretion from the maturation of DCs and elicits a T helper type 2-biased effector T-cell response (Zeituni et al., 2009). Dendritic cells are regarded as immune ‘sentinels’ that determine the fate of infection through activation of immunity or tolerance. This dichotomous response is regulated by pattern recognition receptor crosstalk (Hajishengallis & Lambris, 2011), which triggers distinctive intracellular signaling pathways (e.g. STAT3) and transcription factors (e.g. FOXO1). Pattern recognition receptors on DCs include TLRs, Nod-like receptors and the endocytic C-type lectins such as DC-SIGN (CD209) and mannose receptor (Hammer & Ma, 2013). As DC-SIGN and TLR2 on DCs are targeted by P. gingivalis Mfa1 and FimA fimbriae, respectively (El-Awady et al., 2015) the analysis of the unique genes activated in DCs by these fimbriae-deficient strains becomes a powerful model system to examine how microbes disrupt immune homeostasis. In this study, DPG3-infected MoDCs upregulated STAT3 and DC-SIGN mRNA. This is consistent with the reported role for DC-SIGN ligation (i.e. by Kaposi’s sarcoma-associated herpesvirus) in induction of STAT3 activation, leading to DC dysfunction (Santarelli et al., 2014). STAT3 induction in DCs also correlates with block of autophagy, leading to persistence of Kaposi’s sarcoma-associated herpesvirus (Santarelli et al., 2014) and DPG3 in DCs (El-Awady et al., 2015). Moreover, engagement of TLR2 on DCs by FimA of strain MFI (El-Awady et al., 2015) activates DC maturation (Zeituni et al., 2009) and as shown here, downregulation of DC-SIGN and upregulation of TLR2.

ZNF366 or DC-SCRIPT (cDNA-encoding DC-specific transcript) is a novel protein member of the zinc finger family of transcription factors and is expressed in all DC subsets (Triantis et al., 2006). DC-SCRIPT plays an important role in DC differentiation and maturation. DC-SCRIPT–silenced DCs are less capable of inducing T-cell proliferation (Hontelez et al., 2012). DC-SCRIPT was prominent among the genes upregulated in Pg381-infected DCs. In vitro studies from our group have validated the ability of Pg381 and DPG3 at a low MOI to induce DC differentiation from human monocytes in the absence of GM-CSF/IL-4, the canonical growth factor/cytokine normally used to generate MoDCs from monocytes (Miles et al., 2013).

Among other activities, FOXO1 is involved in the regulation of programmed cell death (apoptosis), necessary for clearance of dysfunctional immune cells and homeostasis (Hou & Van Parijs, 2004). We show here high levels of FOXO1 in DCs infected in vitro with Pg381 and DPG3, but not uninfected control. Moreover, pro-apoptotic Bcl-2 member Bim was not induced by DPG3-infected DCs, explaining the high resistance of these non-canonical MoDCs to apoptosis (Miles et al., 2013). Moreover, the pro-apoptosis-related genes, especially BH3-only proteins (BAD, BAX), are upregulated by Pg381 and MFI but downregulated by DPG3. Efforts in the laboratory are directed towards validating whether or not FOXO1 is active or inactivated by phosphorylation in DCs infected with P. gingivalis DPG3.

Interestingly, mRNA for the immunoregulatory enzyme IDO1 shows significant upregulation after infection with DPG3, and upregulation was also detected in Pg381-infected MoDCs. MFI similarly upregulated IDO1 mRNA whereas, MFB-infected cells showed the lowest upregulation of IDO1. IDO catalyzes the breakdown of tryptophan needed for T-cell proliferation and in chronically inflamed sites, IDO blocks T helper type 1 and type 17 effector differentiation, promoting T-cell apoptosis and FOXP3+ regulatory T-cell formation (Huang et al., 2010). Efforts in our laboratory are directed to determining whether IL-23α, IL-1β, IL-10 and IDO1 proteins are selectively induced in DCs by the different P. gingivalis strains. We are particularly interested in whether DPG3-infected DCs will produce low levels of IL-23, IL-1β and IL-17 relative to MFI and Pg381, as we expect. These inflammatory mediators have previously been reported to be elevated in patients with periodontitis (Davanian et al., 2012). In support of our current study, these cytokines, notably tumor necrosis factor-α, CCL2 (MCP-1), IL-8, IL-6, and IL-1β were elevated by Pg381-infected MoDCs. Moreover, IL-6 and CCL2 also increased by DPG3 that recruits DCs to the sites of inflammation.

It has been shown that P. gingivalis inhibits the production of the chemokine MCP-1 by P. gingivalis-specific T cells, monocytes and B cells (Gemmell et al., 2001). Porphyromonas gingivalis also inhibits neutrophil chemotaxis (Madianos et al., 1997) as well as influx and activation of monocytes/macrophages (Hajishengallis et al., 2008). In the present report we find differential induction of chemokines and chemokine receptors depending on fimbrial expression patterns of the P. gingivalis strain. In general, upregulation of CCL19, CCL2, CCR7, and CCL5 mRNA are dependent on fimbrial expression (or internalization as all the fimbriated strains are taken up by DCs (Zeituni et al., 2009). It is notable that although CCR7 mRNA is upregulated in DCs infected with P. gingivalis the protein is not expressed, resulting in disruption of secondary lymphoid organ homing (Miles et al., 2013). It is also important to note that Pg381 downregulated CCL21, CCR2 and CXCL16 mRNA, whereas DPG3 downregulated CCL21, CCR2, and CX3CR1 and MFI downregulated CCL21 only. Likewise, MFB downregulated CCL19, CCL21, CCR2, and CXCR1 mRNA. Efforts in our laboratory are directed to understanding how these differential chemokine responses translate to DC and T-cell recruitment to the gingival tissues during different stages of the disease, as they are potential targets for therapy (Gemmell et al., 2001).

We further showed that lectin-like oxidized low-density lipoprotein receptor-1 (LOX1) mRNA was significantly upregulated in DPG3-infected cells compared with LOX1 expression in cells infected with Pg381. LOX-1 is a pattern recognition receptor for a variety of endogenous and exogenous ligands. LOX-1 expressed on B cells and DC cells has complementary functions to promote humoral immune responses (Joo et al., 2014). The TLRs play a critical role in the early innate immune response to invading pathogens by sensing microorganisms, and are involved in detecting endogenous danger signals. Signaling by TLRs results in a variety of cellular responses including the production of interferons, proinflammatory cytokines, and effector cytokines that direct the adaptive immune response (Rakoff-Nahoum & Medzhitov, 2009). TLR2 is essential for the recognition of a variety of pathogen-associated microbial patterns from gram-positive bacteria, including bacterial lipoproteins. Our results show that TLR2 has been noticeably upregulated in comparison with MFB-infected cells, which did not change the gene expression within MoDCs. There is statistical significance only in MFI-and MFB-infected cells even though all strains down-regulated the expression of TLR4, the receptor for gram-negative enterobacterial lipopolysaccharide.

Collectively, our results highlight the consequence for genes involved in immune homeostasis, of selective DC-SIGN and TLR2 engagement by P. gingivalis fimbriae (El-Awady et al., 2015). We propose that this DC-SIGN-TLR2 crosstalk represents a microbial ‘switch’ that regulates immune homeostasis and the T-cell effector response (see Fig. S2). These findings will further advance the understanding of the pathogenesis of periodontal diseases; eventually leading to the identification of novel candidate molecules for pathogen-specific therapeutic approaches to chronic inflammatory diseases. Further investigation is warranted to validate these genes at the level of protein, function and in controlled human studies, to eventually provide important clues for therapeutics.

Supplementary Material

Sup Table S1
Sup. Fig 1

Acknowledgments

This work was supported by the National Institutes of Health/NIDCR grant: RO1 DE14328-09.

Footnotes

SUPPORTING INFORMATION

Additional supporting information may be found in the online version of this article at the publisher’s web-site.

References

  1. Bardill JP, Hammer BK. Non-coding sRNAs regulate virulence in the bacterial pathogen Vibrio cholerae. RNA Biol. 2012;9:392–401. doi: 10.4161/rna.19975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beck DA, Hendrickson EL, Vorobev A, et al. An integrated proteomics/transcriptomics approach points to oxygen as the main electron sink for methanol metabolism in Methylotenera mobilis. J Bacteriol. 2011;193:4758–4765. doi: 10.1128/JB.05375-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carrion J, Scisci E, Miles B, et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol. 2012;189:3178–3187. doi: 10.4049/jimmunol.1201053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cutler CW, Kalmar JR, Arnold RR. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun. 1991;59:2097–2104. doi: 10.1128/iai.59.6.2097-2104.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davanian H, Stranneheim H, Bage T, Lagervall M, Jansson L, Lundeberg J, Yucel-Lindberg T. Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing. PLoS One. 2012;7:e46440. doi: 10.1371/journal.pone.0046440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eke PI, Dye BA, Wei L, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86:611–622. doi: 10.1902/jop.2015.140520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. El-Awady AR, Miles B, Scisci E, et al. Porphyromonas gingivalis evasion of autophagy and intracellular killing by human myeloid dendritic cells involves DC-SIGN-TLR2 crosstalk. PLoS Pathog. 2015;10:e1004647. doi: 10.1371/journal.ppat.1004647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol. 2001;125:134–141. doi: 10.1046/j.1365-2249.2001.01511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibson FC, III, Yumoto H, Takahashi Y, Chou HH, Genco CA. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res. 2006;85:106–121. doi: 10.1177/154405910608500202. [DOI] [PubMed] [Google Scholar]
  10. Griffen AL, Becker MR, Lyons SR, Moeschberger ML, Leys EJ. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol. 1998;36:3239–3242. doi: 10.1128/jcm.36.11.3239-3242.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hajishengallis G, Lambris JD. Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol. 2011;11:187–200. doi: 10.1038/nri2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hajishengallis G, Wang M, Liang S, et al. Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3. Adv Exp Med Biol. 2008;632:203–219. doi: 10.1007/978-0-387-78952-1_15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hammer GE, Ma A. Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol. 2013;31:743–791. doi: 10.1146/annurev-immunol-020711-074929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirano T, Beck DA, Demuth DR, Hackett M, Lamont RJ. Deep sequencing of Porphyromonas gingivalis and comparative transcriptome analysis of a LuxS mutant. Front Cell Infect Microbiol. 2012;2:79. doi: 10.3389/fcimb.2012.00079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. ‘t Hoen PA, Ariyurek Y, Thygesen HH, et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res. 2008;36:e141. doi: 10.1093/nar/gkn705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hontelez S, Ansems M, Karthaus N, et al. Dendritic cell-specific transcript: dendritic cell marker and regulator of TLR-induced cytokine production. J Immunol. 2012;189:138–145. doi: 10.4049/jimmunol.1103709. [DOI] [PubMed] [Google Scholar]
  17. Hou WS, Van Parijs L. A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat Immunol. 2004;5:583–589. doi: 10.1038/ni1071. [DOI] [PubMed] [Google Scholar]
  18. Hovik H, Yu WH, Olsen I, Chen T. Comprehensive transcriptome analysis of the periodontopathogenic bacterium Porphyromonas gingivalis W83. J Bacteriol. 2012;194:100–114. doi: 10.1128/JB.06385-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Huang L, Baban B, Johnson BA, III, Mellor AL. Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol. 2010;29:133–155. doi: 10.3109/08830180903349669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hutchins AP, Takahashi Y, Miranda-Saavedra D. Genomic analysis of LPS-stimulated myeloid cells identifies a common pro-inflammatory response but divergent IL-10 anti-inflammatory responses. Sci Rep. 2015;5:9100. doi: 10.1038/srep09100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Isabella VM, Clark VL. Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae. BMC Genom. 2011;12:51. doi: 10.1186/1471-2164-12-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Joo H, Li D, Dullaers M, et al. C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses. Immunity. 2014;41:592–604. doi: 10.1016/j.immuni.2014.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koh SS, Wei JP, Li X, et al. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases. Mod Pathol. 2012;25:828–837. doi: 10.1038/modpathol.2012.32. [DOI] [PubMed] [Google Scholar]
  24. Kuboniwa M, Lamont RJ. Subgingival biofilm formation. Periodontol 2000. 2010;52:38–52. doi: 10.1111/j.1600-0757.2009.00311.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kuboniwa M, Hendrickson EL, Xia Q, et al. Proteomics of Porphyromonas gingivalis within a model oral microbial community. BMC Microbiol. 2009;9:98. doi: 10.1186/1471-2180-9-98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244–1263. doi: 10.1128/mmbr.62.4.1244-1263.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lamont RJ, El-Sabaeny A, Park Y, Cook GS, Costerton JW, Demuth DR. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates. Microbiology. 2002;148:1627–1636. doi: 10.1099/00221287-148-6-1627. [DOI] [PubMed] [Google Scholar]
  28. Lenz DH, Miller MB, Zhu J, Kulkarni RV, Bassler BL. CsrA and three redundant small RNAs regulate quorum sensing in Vibrio cholerae. Mol Microbiol. 2005;58:1186–1202. doi: 10.1111/j.1365-2958.2005.04902.x. [DOI] [PubMed] [Google Scholar]
  29. Madianos PN, Papapanou PN, Sandros J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun. 1997;65:3983–3990. doi: 10.1128/iai.65.10.3983-3990.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mann B, Van Opijnen T, Wang J, et al. Control of virulence by small RNAs in Streptococcus pneumoniae. PLoS Pathog. 2012;8:e1002788. doi: 10.1371/journal.ppat.1002788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Miles B, Scisci E, Carrion J, Sabino GJ, Genco CA, Cutler CW. Noncanonical dendritic cell differentiation and survival driven by a bacteremic pathogen. J Leukoc Biol. 2013;94:281–289. doi: 10.1189/jlb.0213108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Miles B, Abdel-Ghaffar KA, Gamal AY, Baban B, Cutler CW. Blood dendritic cells: “canary in the coal mine” to predict chronic inflammatory disease? Front Microbiol. 2014;5:6. doi: 10.3389/fmicb.2014.00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mortazavi A, Williams BA, Mccue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5:621–628. doi: 10.1038/nmeth.1226. [DOI] [PubMed] [Google Scholar]
  34. Njoroge T, Genco RJ, Sojar HT, Hamada N, Genco CA. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun. 1997;65:1980–1984. doi: 10.1128/iai.65.5.1980-1984.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Oliver HF, Orsi RH, Ponnala L, et al. Deep RNA sequencing of L. monocytogenes reveals overlapping and extensive stationary phase and sigma B-dependent transcriptomes, including multiple highly transcribed noncoding RNAs. BMC Genom. 2009;10:641. doi: 10.1186/1471-2164-10-641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ortega AD, Gonzalo-Asensio J, Garcia-Del Portillo F. Dynamics of Salmonella small RNA expression in non-growing bacteria located inside eukaryotic cells. RNA Biol. 2012;9:469–488. doi: 10.4161/rna.19317. [DOI] [PubMed] [Google Scholar]
  37. Palm E, Khalaf H, Bengtsson T. Porphyromonas gingivalis downregulates the immune response of fibroblasts. BMC Microbiol. 2013;13:155. doi: 10.1186/1471-2180-13-155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Perkins TT, Kingsley RA, Fookes MC, et al. A strand-specific RNA-Seq analysis of the transcriptome of the typhoid bacillus Salmonella typhi. PLoS Genet. 2009;5:e1000569. doi: 10.1371/journal.pgen.1000569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9:57–63. doi: 10.1038/nrc2541. [DOI] [PubMed] [Google Scholar]
  40. Redanz S, Standar K, Podbielski A, Kreikemeyer B. A five-species transcriptome array for oral mixed-biofilm studies. PLoS ONE. 2011;6:e27827. doi: 10.1371/journal.pone.0027827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–1118. doi: 10.1084/jem.179.4.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Santarelli R, Gonnella R, Di Giovenale G, et al. STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells. Sci Rep. 2014;4:4241. doi: 10.1038/srep04241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sukhithasri V, Nisha N, Biswas L, Anil Kumar V, Biswas R. Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions. Microbiol Res. 2013;168:396–406. doi: 10.1016/j.micres.2013.02.005. [DOI] [PubMed] [Google Scholar]
  44. Takahashi Y, Davey M, Yumoto H, Gibson FC, III, Genco CA. Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell Microbiol. 2006;8:738–757. doi: 10.1111/j.1462-5822.2005.00661.x. [DOI] [PubMed] [Google Scholar]
  45. Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7:562–578. doi: 10.1038/nprot.2012.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Triantis V, Trancikova DE, Looman MW, Hartgers FC, Janssen RA, Adema GJ. Identification and characterization of DC-SCRIPT, a novel dendritic cell-expressed member of the zinc finger family of transcriptional regulators. J Immunol. 2006;176:1081–1089. doi: 10.4049/jimmunol.176.2.1081. [DOI] [PubMed] [Google Scholar]
  47. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57–63. doi: 10.1038/nrg2484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wilhelm BT, Marguerat S, Watt S, et al. Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution. Nature. 2008;453:1239–1243. doi: 10.1038/nature07002. [DOI] [PubMed] [Google Scholar]
  49. Xie H, Cai S, Lamont RJ. Environmental regulation of fimbrial gene expression in Porphyromonas gingivalis. Infect Immun. 1997;65:2265–2271. doi: 10.1128/iai.65.6.2265-2271.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yilmaz O, Verbeke P, Lamont RJ, Ojcius DM. Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect Immun. 2006;74:703–710. doi: 10.1128/IAI.74.1.703-710.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yoder-Himes DR, Chain PS, Zhu Y, et al. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci USA. 2009;106:3976–3981. doi: 10.1073/pnas.0813403106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zeituni AE, Jotwani R, Carrion J, Cutler CW. Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J Immunol. 2009;183:5694–5704. doi: 10.4049/jimmunol.0901030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zeituni AE, Carrion J, Cutler CW. Porphyromonas gingivalis–dendritic cell interactions: consequences for coronary artery disease. J Oral Microbiol. 2010a;2:5782. doi: 10.3402/jom.v2i0.5782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zeituni AE, Mccaig W, Scisci E, Thanassi DG, Cutler CW. The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J Bacteriol. 2010b;192:4103–4110. doi: 10.1128/JB.00275-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zenobia C, Hajishengallis G. Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis. Virulence. 2015;6:236–243. doi: 10.1080/21505594.2014.999567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zhang B, Elmabsout AA, Khalaf H, et al. The periodontal pathogen Porphyromonas gingivalis changes the gene expression in vascular smooth muscle cells involving the TGFbeta/Notch signalling pathway and increased cell proliferation. BMC Genom. 2013;14:770. doi: 10.1186/1471-2164-14-770. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Sup Table S1
Sup. Fig 1

RESOURCES